Toll Free Tel: 1-866-789-3784
       

GlobalDrugsDirect.com is Moving!

GlobalDrugDirect.com is merging with our flagship website CanadaPharmacyOnline.com. CPO provides the same prices for products from the same suppliers and the same outstanding customer service for customers.
If you are an existing customer, your account will be transferred to CPO.
You can do the transfer your self by clicking Transfer to CPO.
If you have any questions, please call GlobalDrugsDirect customer service at 1-866-789-3784. A customer service representative will answer your questions and do the transfer for you.
Not an existing customer? It is a good opportunity to open your account with us by clicking CanadaPharmacyOnline.com.
Chemical Name: Ciprofloxacin
Type
Product
Mfr.
Country
Dosage
Qty
Price(USD)
Type:
Product:Ciloxan Eye Ointment
Manufacturer:Novartis
Country:Canada
Dosage:0.3 %/3.5 gm
Qty:1
Price:$37.99
        
        
Type:
Product:Ciloxan Eye Drops
Manufacturer:Novartis
Country:Canada
Dosage:0.3 %/5 ml
Qty:1
Price:$37.99
        
        
Type:
Product:Ciprofloxacin Eye Drops
Manufacturer:Generic
Country:Canada
Dosage:0.3 %/5 ml
Qty:1
Price:$23.99
        
        

Ciloxan Information
Ciloxan ophthalmic solution and Ciloxan ophthalmic ointment are indicated for the treatment of infections caused by susceptible strains of microorganisms in conjunctivitis (solution and ointment) and corneal ulcers (solution only). Ciloxan solution and ointment contain ciprofloxacin, a fluoroquinolone antibacterial that is active against a broad spectrum of ocular pathogens and delivers both penetration and potency. Ciloxan ophthalmic solution and ointment should be discontinued at the first appearance of a skin rash or any other signs of hypersensitivity reaction. As with other antibacterial preparations, prolonged use of ciprofloxacin may result in overgrowth of nonsusceptible organisms including fungi.

Ciloxan Side Effects
Local burning and ocular discomfort may occur as well as itching, foreign body sensation, lid margin crusting, crystals/scales, conjunctival hyperaemia and bad taste following instillation. Additionally, corneal staining, keratopathy/keratitis, allergic reactions, lid oedema, tearing, photophobia, corneal infiltrates, nausea and decreased vision have been reported. Hypersensitivity reactions cannot be excluded. In patients with corneal ulcer and frequent administration of the drug, white precipitates have been observed which resolved after continuous application of CILOXAN. The precipitate does not preclude the continued use of CILOXAN nor does it adversely affect the clinical course of the ulcer or the visual outcome. The onset of the precipitate was within 24 hours to 7 days after starting therapy. Resolution of the precipitate varied from immediately to 13 days after therapy commencing.

The generic alternative is not manufactured by the company that makes the brand product.

All prices are in US dollars.

The content on this page has been supplied to GlobalDrugsDirect.com by an independent third party contracted to provide information for our website. GlobalDrugsDirect relies on these third parties to create and maintain this information and cannot guarantee the medical efficacy, accuracy or reliability of the information that has been provided to us. If you require any advice or information about the drugs on this page, a medical condition or treatment advice, you should always speak to a health professional. Please note that not all products, including any referenced in this page, are shipped by our affiliated Canadian Pharmacy. We affiliate with other dispensaries that ship product to our customers from the following jurisdictions: Canada, Singapore, New Zealand, Turkey, Mauritius, India, and United Kingdom. The items in your order maybe shipped from any of the above jurisdictions. The products are sourced from various countries as well as those listed above. Rest assured, we only affiliate with our authorized dispensaries that procure product through reliable sources.

© Copyright 2006 - 2024 GlobalDrugsDirect.com. All Rights Reserved.